Skip to main content

Advertisement

Log in

Artificial intelligence universal biomarker prediction tool

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Through experiencing cardiopulmonary arrest, an artificial intelligence universal biomarker prediction tool was developed to help patients understand improvement in the trends of their disease. PyPI tool handles two biomarkers, hbA1c for diabetes and NP-proBNP for heart failure, to predict the next hospital visit. Predicting improvement in disease is a great hope for patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data sharing statement

Not applicable.

References

  1. Bellagambi FG, Petersen C, Salvo P et al (2021) Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring Heart Failure. Sci Rep 11:13088. https://doi.org/10.1038/s41598-021-92488-2

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  2. Klein KR, Buse JB (2020) The trials and tribulations of determining HbA1c targets for Diabetes Mellitus. Nat Rev Endocrinol 16:717–730. https://doi.org/10.1038/s41574-020-00425-6

    Article  CAS  PubMed  Google Scholar 

  3. PyPI. phope. https://pypi.org/project/phope/ Access on 18 April 2023

  4. Błaziak M, Urban S, Wietrzyk W, Jura M, Iwanek G, Stańczykiewicz B, Kuliczkowski W, Zymliński R, Pondel M, Berka P, Danel D, Biegus J, Siennicka A (2022) An Artificial Intelligence Approach to guiding the management of Heart Failure patients using predictive models: a systematic review. Biomedicines 10(9):2188. https://doi.org/10.3390/biomedicines10092188

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wang M, Hng TM (2021) HbA1c: More than just a number. Aust J Gen Pract. ;50(9):628–632. https://doi.org/10.31128/AJGP-03-21-5866. PMID: 34462769

  6. Samad M, Malempati S, Restini CBA (2023) Natriuretic Peptides as biomarkers: Narrative Review and considerations in Cardiovascular and respiratory dysfunctions. Yale J Biol Med 96(1):137–149. https://doi.org/10.59249/NCST6937PMID: 37009194; PMCID: PMC10052602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rodolaki K, Pergialiotis V, Sapantzoglou I, Theodora M, Antsaklis P, Pappa K, Daskalakis G, Papapanagiotou A (2023) N-Terminal Pro-B type natriuretic peptide as a predictive biomarker of Bronchopulmonary Dysplasia or Death due to Bronchopulmonary Dysplasia in Preterm neonates: a systematic review and Meta-analysis. J Pers Med 13(9):1287. https://doi.org/10.3390/jpm13091287PMID: 37763055; PMCID: PMC10532602

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Grant and award info: This research has no fund.

Author information

Authors and Affiliations

Authors

Contributions

YT completed this research and wrote the program and this article.

Corresponding author

Correspondence to Yoshiyasu Takefuji.

Ethics declarations

Competing interests

The author has no conflict of interest.

Ethical approval

Information, institution(s) and number(s): Not applicable.

Patient involvement

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takefuji, Y. Artificial intelligence universal biomarker prediction tool. J Thromb Thrombolysis 57, 341–343 (2024). https://doi.org/10.1007/s11239-023-02930-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-023-02930-7

Keywords

Navigation